Serum epidermal growth factor receptor and p53 as predictors of lung cancer risk in the ATBC study

Reference

• ADAMI, H.-O. and BARON, J. 1994, Screening for prostate cancer: are we ready? Cancer Epidemiology Biomarkers & Prevention, 3,193–195.
   PubMed Web of Science ®Google Scholar
• ANGELOPOULOU, K., ROSEN, B., STRATIS, M., YU, H., SOLOMOU, M. and DIAMANDIS, E. P. 1996, Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathological features and survival. Cancer, 78, 2146–2152.
   PubMed Web of Science ®Google Scholar
• ATBC STUDY GROUP 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine; 330, 1029–1035.
   PubMed Web of Science ®Google Scholar
• BRANDT-RAUF, P. W. 1992, The molecular epidemiology of oncoproteins. Scandinavian Journal of Work and Environmental Health, 18 (Suppl. 1), 46–49.
   PubMedGoogle Scholar
• BRANDT-RAUF, E, SMITH, S., HEMMINKI, K., KOSKINEN, H., VAINIO, H., NIMAN, H. and FORD, J. 1992, Serum oncoproteins and growth factors in asbestosis and silicosis patients. International Journal of Cancer, 50, 881–885.
   PubMed Web of Science ®Google Scholar
• BRANDT-RAUF, P. W., LUO, J.-C., CARNEY, W., SMITH, S., DEVIVO, I., MILLING, C., HEMMINKI, K., KOSKINEN, H., VAimo, H. and NEUGUT, A. I. 1994, Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans. International Journal of Cancer, 56, 383–386.
   Google Scholar
• BRANDT-RAUF, P.W., DEVIVO, I., MARION, M.-J. and HEMMINKI, K. 1995, The molecular epidemiology of growth signal trasduction proteins. Journal of Occupational and Environmental Medicine; 37, 77–83.
   Google Scholar
• BRESLOW, N. E. and DAY, N. E. 1980, Statistical Methods in Cancer Research, Vol I: The Analysis of Case-Control Studies, IARC Scientific Publications No. 32 (Lyon: IARC).
   Google Scholar
• CADENA, D. L. and GILL, G. N.1992, Receptor tyrosine kinases. The FASEB Journal, 6,2332-2337. DEVITA, V. T., HELLMAN, S. and ROSENBERG, S. A. 1997, Cancer, Principles & Practice of Oncology, 5th edition (Philadelphia: J.B. Lippincott).
   Google Scholar
• FONTANINI, G., FIORE, L., BIGINI, D., VIGNAT I, S., CALVO, S., MUSSI, A., LUCCHI, M, ANGELETTI, C. A., MERLO, G. and BASOLO G. 1994, Levels of p53 in the serum of non-small cell lung cancer patients correlate with positive p53 immunohistochemistry on tumor sections, tumor necrosis and nodal involvement. International Journal of Oncology, 5,553–558.
   Google Scholar
• GRECO, C., GANDOLFO, G. M., MATTEI, E, GRADILONE, A., ALVINO, S., PASTORE, L.I., CASALE, V., CASOL EE, GRASSI, A., CIANCIULLI, M. and AGLIANO, M. 1994, Detection of c-myc genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions. Anticancer Research, 14, 1433–1440.
   PubMed Web of Science ®Google Scholar
• HEMMINKI, K., PARTANEN, R., KOSKINEN, H., SMITH, S., CARNEY, W. and BRANDT-RAUF, P. W. 1996, The molecular epidemiology of oncoproteins. Serum p53 protein in patients with asbestosis. Chest, 109, 22S–26S.
   Google Scholar
• HUSGAFVEL-PURSIAINEN, K., KANNIO, A., OKSA, P., SUITIALA, T., KOSKINEN, H., PARTANEN, R., HEMMINKI, K., SMITH, S., ROSENSTOCK-LEB3U, R. and BRANDT-RAUF, P. W. 1997, Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environmental and Molecular Mutagenesis, 30,224–230.
   Google Scholar
• LAIRD, N. M. and WARE, J. H. 1982, Random-effects models for longitudinal data. Biometrics, 38, 963–974.
   PubMed Web of Science ®Google Scholar
• LEHTINEN, T., LU OS TARINEN T DILLNER, J., AROMAA, A., HAKAMA, M., HAKULINEN, T., KNEKT, E, LEINIKKI, P., Lumio, J., LAHDENSUO, M. L., MAATELA, J., TEPPO, L. and LEHTINEN, M. 1996, Serum p53 accumulation and altered antibody response to Ebstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin. British Journal of Haematology, 93, 104–110.
   Google Scholar
• LUBIN R., ZALCMAN G., BOUCHET L., TREDANIEL J., LEGRos Y, CAZALS D., HIRSH A. and Soussi T. 1995, Serum p53 antibodies as early markers of lung cancer. Nature Med. 1, 701–702.
   PubMed Web of Science ®Google Scholar
• MCKENZIE, S. J. 1991, Diagnostic utility of oncogenes and their products in human cancer. Biochimica et Biophysica Acta, 1072,193–214.
   PubMed Web of Science ®Google Scholar
• PARTANEN, R., HEMMINKI, K., BRANDT-RAUF, P., JIN, C.-G. and KOSKINEN, H. 1994a, Serum levels of growth factor receptors, EGFR and Neu in asbestosis patients: A follow-up study. International Journal of Oncology, 4, 1025–1028.
   Google Scholar
• PARTANEN, R., HEMMINKI, K., KOSKINEN, H., Luo, J.-C., CARNEY, W. P. and BRANDT-RAUF, P .W. 1994b, The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. Journal of Occupational Medicine,36, 1324–1328.
   Google Scholar
• PENN, A. and SNYDER, C. A. 1996,1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates artherosclerotic plaque development. Circulation, 93, 552–557.
   PubMed Web of Science ®Google Scholar
• RAEDLE, J., OREMEK, G., WELKER, M., ROTH, W. K., CASPARY, W. F. and ZEUZEM, S. 1996, p53 autoantibodies in patients with pancreatic carcinoma. Pancreas, 13, 241–246.
   PubMed Web of Science ®Google Scholar
• SEGAWA, Y., TAKIGAWA, N., MANDAI, K., MAEDA,Y, TAKATA, I., FUJIMOTO, N. and JINNO, K. 1997, Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinocopathological evaluation. Lung Cancer, 16, 229–238.
   Google Scholar
• SUWA, H., OHSHIO, G., OKADA, N., WANG, Z., FUKUMOTO, M., IMAMURA, T. and IMAMURA, M. 1997, Clinical significance of serum p53 antigen in patients with pancreatic carcinomas. Gut, 40, 647–653.
   PubMed Web of Science ®Google Scholar
• TRUMPER, L., JUNG, W., DAHL, G., DIEHL, V., GAUSE, A. and PFREUNDSCHUH, M. 1994, Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevatedated in serum of patients with Hodkin's disease. Acta Oncologica, 5\(Supp1.1), 93–96.
   Google Scholar
• WATERFIELD, M. D., MAYES, E. L. V., STROOBANT, P., BENNET, P. L. P., YOUNG, S., GOODFELLOW,
   Google Scholar
• P.N., BANTING, G. S. and OZANNE, B. A. 1982, Monoclonal antibody to the human epidermal growth factor receptor. Journal of Cellular Biochemistry, 20, 149–161.
   Google Scholar
• WOLLENBERG, B., JAN, N. V., PITZKE, P, REITER, W. and STIEBER, P. 1997, Anti-p53 antibodies in serum of smokers and head and neck carcer patients. Anticancer Research, 17,413–418.
   PubMed Web of Science ®Google Scholar